This article is- freely available
- re-usable
Article
Quantitative Structure-Activity Relationship Studies on Indenoisoquinoline Topoisomerase I Inhibitors as Anticancer Agents in Human Renal Cell Carcinoma Cell Line SN12C
Yi Zhi 1 
,
Jin Yang 2 
,
Shengchao Tian 1 
,
Fang Yuan 1 
,
Yang Liu 1,† 
,
Yi Zhang 2 
,
Pinghua Sun 3 
,
Bo Song 1,*

and
Zhiwen Chen 1,*

1
Urology Center, Southwest Hospital, Third Military Medical University, Chongqing 400038, China
2
Department of Cell Biology, Third Military Medical University, Chongqing 400038, China
3
Guangdong Province Key Laboratory of Pharmacodynamic Constituents of Traditional Chinese Medicine and New Drugs Research, College of Pharmacy, Jinan University, Guangzhou 510632, China
†
Current address: Department of Urology, the 452nd Hospital of People’s Liberation Army, Chengdu 610021, China.
* Authors to whom correspondence should be addressed.
Received: 9 March 2012; in revised form: 4 May 2012 / Accepted: 11 May 2012 / Published: 18 May 2012
Abstract: Topoisomerase I is important for DNA replication and cell division, making it an attractive drug target for anticancer therapy. A series of indenoisoquinolines displaying potent Top1 inhibitory activity in human renal cell carcinoma cell line SN12C were selected to establish 3D-QSAR models using CoMFA and CoMSIA methods. Internal and external cross-validation techniques were investigated, as well as some measures taken, including region focusing, bootstrapping and the “leave-group-out” cross-validation method. The satisfactory CoMFA model predicted a q2 value of 0.659 and an r2 value of 0.949, indicating that electrostatic and steric properties play a significant role in potency. The best CoMSIA model, based on a combination of steric, electrostatic and H-bond acceptor descriptors, predicted a q2 value of 0.523 and an r2 value of 0.902. The models were graphically interpreted by contour plots which provided insight into the structural requirements for increasing the activity of a compound, providing a solid basis for future rational design of more active anticancer agents.
Keywords: CoMFA; CoMSIA; QSAR; indenoisoquinoline; Top1 inhibitors
Article Statistics
Click here to load and display the download statistics.
Notes: Multiple requests from the same IP address are counted as one view.
Cite This Article
MDPI and ACS Style
Zhi, Y.; Yang, J.; Tian, S.; Yuan, F.; Liu, Y.; Zhang, Y.; Sun, P.; Song, B.; Chen, Z. Quantitative Structure-Activity Relationship Studies on Indenoisoquinoline Topoisomerase I Inhibitors as Anticancer Agents in Human Renal Cell Carcinoma Cell Line SN12C. Int. J. Mol. Sci. 2012, 13, 6009-6025.
AMA Style
Zhi Y, Yang J, Tian S, Yuan F, Liu Y, Zhang Y, Sun P, Song B, Chen Z. Quantitative Structure-Activity Relationship Studies on Indenoisoquinoline Topoisomerase I Inhibitors as Anticancer Agents in Human Renal Cell Carcinoma Cell Line SN12C. International Journal of Molecular Sciences. 2012; 13(5):6009-6025.
Chicago/Turabian Style
Zhi, Yi; Yang, Jin; Tian, Shengchao; Yuan, Fang; Liu, Yang; Zhang, Yi; Sun, Pinghua; Song, Bo; Chen, Zhiwen. 2012. "Quantitative Structure-Activity Relationship Studies on Indenoisoquinoline Topoisomerase I Inhibitors as Anticancer Agents in Human Renal Cell Carcinoma Cell Line SN12C." Int. J. Mol. Sci. 13, no. 5: 6009-6025.